Abstract is: Giulio Superti-Furga (born 17 May 1962 in Milan) is an Italian molecular and systems biologist based in Vienna, Austria, and a member of the Scientific Council of the ERC (European Research Council). He is the Scientific Director of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, and Professor of Medical Systems Biology at the Medical University of Vienna. Amongst his most significant scientific achievements to date are the elucidation of basic regulatory mechanisms of tyrosine kinases in human cancers, the identification of the molecular mechanisms of several drugs, and the discovery of fundamental organization principles of the proteome and the lipidome of higher organisms, as well as the characterization of molecular components relevant for innate immunity. His work has directly contributed to a systems-level understanding of pathogen infections in host cells and of the mechanism of action of specific drugs. He is an advocate for the adoption of systems biology approaches for medicine and in particular for drug discovery. Recently, he has argued that membrane transporters at the interface between biological systems and the environment, despite their relevance for medicine and drug discovery, are understudied and request a concerted systematic effort by the scientific community. As scientific director of CeMM he aims at fostering a precise and predictive medicine by combining free-minded basic research with clinical expertise and made innovative diagnostic and therapeutic approaches his prime concern. According to Google Scholar Giulio Superti-Furga has published more than 200 manuscripts that have been collectively cited > 28,000 times, reflected by an h-index of 75. The paper "Functional organization of the yeast proteome by systematic analysis of protein complexes" by Gavin, AC*, 36 authors, Superti-Furga G* (* shared correspondence), Nature 2002, 10 Jan; 414:141–147 has been cited > 5,000 times (Google Scholar) and is a Faculty of 1000 All Time Top 10 paper in biology. His current work focuses on drug action and personalized medicine. ORCID ID: 0000-0002-0570-1768 Researcher ID: F-4755-2015
human | Q5 |
P5463 | AE member ID | Superti-Furga_Giulio |
P9985 | EMBO member ID | giulio-superti-furga |
P8168 | FactGrid item ID | Q886224 |
P646 | Freebase ID | /m/064l9tm |
P227 | GND ID | 1158166982 |
P1960 | Google Scholar author ID | dHfTgDwAAAAJ |
P269 | IdRef ID | 116241926 |
P213 | ISNI | 0000000140958895 |
P10299 | Leopoldina member ID (new) | giulio-superti-furga |
P3413 | Leopoldina member ID (superseded) | 1299 |
P496 | ORCID iD | 0000-0002-0570-1768 |
P3829 | Publons author ID | 2407935 |
P1053 | ResearcherID | F-4755-2015 |
P1153 | Scopus author ID | 35355356900 |
P10013 | SNSF person ID | 17423 |
P214 | VIAF ID | 220277600 |
P10832 | WorldCat Entities ID | E39PBJp64TWBJTQBbryyk6jpyd |
P166 | award received | Prize of the City of Vienna for Natural Sciences | Q1804550 |
EMBO Membership | Q26268243 | ||
P27 | country of citizenship | Italy | Q38 |
P69 | educated at | University of Zurich | Q206702 |
P108 | employer | La Jolla Institute for Allergy and Immunology | Q6463245 |
CeMM Research Center for Molecular Medicine | Q30281843 | ||
P734 | family name | Superti-Furga | Q101043198 |
Superti-Furga | Q101043198 | ||
Superti-Furga | Q101043198 | ||
P735 | given name | Giulio | Q17596118 |
Giulio | Q17596118 | ||
P1412 | languages spoken, written or signed | Italian | Q652 |
P463 | member of | Austrian Academy of Sciences | Q299015 |
Academia Europaea | Q337234 | ||
German Academy of Sciences Leopoldina | Q543804 | ||
P106 | occupation | molecular biologist | Q15839206 |
biologist | Q864503 | ||
P21 | sex or gender | male | Q6581097 |